Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

AgenT


Pépinière Genopole Entreprises – 4, rue Pierre Fontaine – Genopole Campus 3
91058 EVRY Cedex – France
Téléphone : 06.11.10.26.95
Email : jerome.braudeau@agent-biotech.com

CEO : Jérôme BRAUDEAU
Web Site >

Booster

#Health / Well-being #Diagnostics

  • Alzheimer
  • Silent phase
  • Diagnostics
  • Preventative treatment
  • Animal model

Field of activity


AgenT is developing an unprecedented blood test to identify patients with Alzheimer’s disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer’s disease.

BACKGROUND

The development of AgenT’s exclusive and patented animal model began in 2012. Its inventor, Jérôme Braudeau, PhD in neurosciences, joined forces thereafter with Baptiste Billoir in 2016 to create AgenT in 2018.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

The only way to find an effective treatment for Alzheimer’s disease is to concentrate on its silent phase (15 to 20 years before its diagnosis as currently practiced).

That is why AgenT is developing an unprecedented silent-phase blood test and treatments to prevent the development of symptoms

ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS

AgenT’s animal model, the foundation of its activities, has been described in mice (Audrain et al, 2016) and rats (Audrain et al, 2017). The scientific aspects of the company’s vision were also validated in a 2018 publication (Souchet et al, 2018).

COLLABORATIONS SOUGHT

AgenT is actively searching for financial (campaign underway), academic and private partners to advance in the fight against Alzheimer’s disease.

  • Further Information

    1 patent (+ 1 exclusive use license)

    STRENGHTS
    The only company working on the silent phase of Alzheimer’s disease and developing a diagnostic test and preventative treatments for deployment in that phase.

    AgenT has the only animal model accurately reproducing the clinical progression of Alzheimer’s disease, particularly in the silent phase.

    AgenT’s founders have renowned expertise in Alzheimer’s disease

    INNOVATION ASSETS
    A unique, disruptive animal model.

Share
Genopole’s Companies

#Diagnostics


In same field

Ciclix - StrokeHub - Genopole's company

Ciclix

Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.

Discover
Echoliv -Genopole's company

ECHOLIV

Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.

Discover
Floating Genes - entreprises génopolitaines

Floating Genes

Floating Genes develops Early cancer diagnosis in liquid biopsies

Discover
DeepTope - Genopole's company

Deeptope

– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
logo GenoSplice - Genopole's Company

GenoSplice

Bioinformatics service provider (gene expression, splicing, SNP, CNV, epigenetics, data integration).

Discover
Endodiag - Genopole's company

Endodiag

Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.

Discover
Enalees - Genopole's company

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
View all >
With the support from